Concepedia

Mênonli Adjobimey

MA

Statistics

Publications

13

Citations

802

H-Index

11

Active since

2016

Affiliations

McGill University(Current)

University of Alberta

BC Centre for Disease Control

University of British Columbia

Padjadjaran University

Mênonli Adjobimey is an author at McGill University specializing in tuberculosis, epidemiology, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

2016–2022

13

Publications

13

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 368 citations · Full text

Safety and Side Effects of Rifampin versus Isoniazid in Children

Thierno Diallo, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 155 citations · Full text

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials

Jonathon R. Campbell, Anete Trajman, Victoria J. Cook et al. · The Lancet Infectious Diseases · 2019 · 63 citations

, , +9

Tuberculosis contact investigation and short-course preventive therapy among young children in Africa

V Schwoebel, Kobto G. Koura, Mênonli Adjobimey et al. · The International Journal of Tuberculosis and Lung Disease · 2020 · 41 citations

Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial

Olivia Oxlade, Andrea Benedetti, Mênonli Adjobimey et al. · The Lancet Public Health · 2021 · 34 citations · Full text

1–5 of 13